Research Information
Tesamorelin
GH Peptides · Synthetic GHRH analogue
Short research overview
Tesamorelin is a synthetic growth-hormone-releasing hormone analogue studied as its own defined compound. Although it shares a GHRH-analogue classification with CJC-1295 without DAC, this page keeps Tesamorelin’s research identity separate rather than treating the two catalogue entries as equivalents.
View the Tesamorelin product page·CJC-1295 without DAC vs TesamorelinHow it is being studied
The supported mechanism context is agonism at the GHRH receptor within pituitary and growth-hormone-axis signalling research. Unlike the CJC-1295 without DAC entry, its defining catalogue name does not centre on the absence of a DAC modification.
Areas of Research
- Tesamorelin-specific GHRH receptor pharmacology
- Pituitary signalling research models
- Growth-hormone-axis studies of a GHRH analogue
Current Research Status
Research reference only. This entry does not represent an approved therapeutic use or medical recommendation.
Available Strength
10mg
Scientific References
Tesamorelin literature index
PubMed · National Library of Medicine
Tesamorelin 10mg analytical certificate
PEPY verification archive
For Research Purposes Only
This information is provided as a scientific reference and does not include medical, dosing, administration or human-use guidance.